Maxvax Biotechnology Limited Liability Company
Clinical trials sponsored by Maxvax Biotechnology Limited Liability Company, explained in plain language.
-
Scientists test RSV vaccine to boost immune memory
Vaccine Not yet recruitingThis study will test a new RSV vaccine in 60 adults aged 20 and older. Researchers want to understand how the vaccine triggers the immune system to create strong antibodies and memory T cells. The goal is to learn how to make RSV vaccines more effective.
Sponsor: MAXVAX Biotechnology Limited Liability Company • Aim: Vaccine
Last updated Jun 27, 2026 13:00 UTC
-
New RSV vaccine trial aims to protect women from respiratory virus
Vaccine Not yet recruitingThis early-stage study tests a new vaccine (MKK900) against respiratory syncytial virus (RSV) in 120 healthy women aged 18 to 49. The main goal is to check if the vaccine is safe and triggers a strong immune response. Participants will receive either the new vaccine or an active …
Phase 1 • Sponsor: MAXVAX Biotechnology Limited Liability Company • Aim: Vaccine
Last updated Jun 27, 2026 12:00 UTC